Tighter regulations proposed for animal testing in UK

By Admin
A report by the Academy of Medical Sciences suggests that tighter regulations should be put in place for animal testing. The writers of the report are...

A report by the Academy of Medical Sciences suggests that tighter regulations should be put in place for animal testing.

The writers of the report are concerned by the increasing popularity of experiments involving the insertion of human materials into animals.

The report praises the benefits of the new technique, which has allowed researchers to test cancer drugs on human tissue attached to mice.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

However, it warns that the involvement of human materials increases the ethical complexity of animal testing. It suggests that current regulations are not always applicable.

For example, the Human Fertilisation and Embryology Authority prohibits the progression of any embryo that contains predominantly human material beyond 14 days. However, for embryos that are mostly animal but contain some human material, there are no regulations in place.

The report recommends three categories for studies involving animal testing, with category three experiments being banned.

The progression of the embryo containing some human material would be classified as a category three experiment.

Category two experiments would be assessed on a case-by-case basis, with the requirement that strong scientific justification must be provided. The addition of human genes to non-human primates would fall under this category.

Finally, category one experiments would be treated as any other test on an animal, with no additional regulations being imposed.

The UK government has said it will consider the proposal.

Share

Featured Articles

PA Consulting: People Want 'Stackable' Healthcare Products

PA Consulting report shows people want ‘stackable’ personalised healthcare products and services that leverage personal data

HIV Testing Landmark Highlights Ongoing AIDS Problems

As US healthcare solutions specialist RMI passes the 350-million HIV testing kit mark, we look at the current HIV/AIDS situation globally

Schneider's Blum on Electricity 4.0 and Healthcare

Olivier Blum, EVP of Schneider Electric’s Energy Management business tells Healthcare Digital how Electricity 4.0 can improve people's wellbeing

Research Breakthrough Promises New Lupus Treatments

Medical Devices & Pharma

Healthcare Systems Worldwide Hit by Global IT Outage

Technology & AI

Abbott Labs' profits soar; Nipro opens First US Facility

Medical Devices & Pharma